Masaki Miyazaki

2.3k total citations
75 papers, 1.2k citations indexed

About

Masaki Miyazaki is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Masaki Miyazaki has authored 75 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 34 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Masaki Miyazaki's work include Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Research Studies (14 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers). Masaki Miyazaki is often cited by papers focused on Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Research Studies (14 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers). Masaki Miyazaki collaborates with scholars based in Japan, Germany and United Kingdom. Masaki Miyazaki's co-authors include Isamu Okamoto, Kazuhiko Nakagawa, Hidetoshi Nakamura, Shotaro Chubachi, Tomoko Betsuyaku, Saeko Takahashi, Mamoru Sasaki, Aihide Yoshino, Mizuha Haraguchi and Soichiro Nomura and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Masaki Miyazaki

70 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masaki Miyazaki Japan	22	591	409	266	140	116	75	1.2k
N Ando Japan	25	538 0.9×	307 0.8×	498 1.9×	62 0.4×	135 1.2×	69	1.9k
Cathie Leister United States	17	300 0.5×	284 0.7×	523 2.0×	41 0.3×	44 0.4×	31	1.1k
Marshall Pitz Canada	23	585 1.0×	697 1.7×	526 2.0×	234 1.7×	33 0.3×	66	2.0k
Eun Joo Kang South Korea	20	589 1.0×	677 1.7×	255 1.0×	172 1.2×	21 0.2×	83	1.4k
Hiroaki Kato Japan	20	447 0.8×	325 0.8×	158 0.6×	80 0.6×	22 0.2×	109	1.9k
Elena Piazza Italy	14	408 0.7×	702 1.7×	117 0.4×	175 1.3×	15 0.1×	31	1.3k
Cheng-Chun Lee Taiwan	23	146 0.2×	175 0.4×	308 1.2×	163 1.2×	22 0.2×	53	1.2k
Yoshinao Abe Japan	19	369 0.6×	137 0.3×	137 0.5×	59 0.4×	23 0.2×	63	1.1k
Hee Joung Kim South Korea	21	582 1.0×	297 0.7×	485 1.8×	50 0.4×	22 0.2×	85	1.5k
Alison Conlin United States	23	663 1.1×	1.1k 2.7×	215 0.8×	79 0.6×	39 0.3×	73	1.8k

Countries citing papers authored by Masaki Miyazaki

Since Specialization

Citations

This map shows the geographic impact of Masaki Miyazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Miyazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Miyazaki more than expected).

Fields of papers citing papers by Masaki Miyazaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Miyazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Miyazaki. The network helps show where Masaki Miyazaki may publish in the future.

Co-authorship network of co-authors of Masaki Miyazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Miyazaki. A scholar is included among the top collaborators of Masaki Miyazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Miyazaki. Masaki Miyazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nomura, Akihiro, Tomoyuki Tanigawa, Yasushi Fukushima, et al.. (2019). Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial. Journal of Medical Internet Research. 21(4). e13520–e13520. 46 indexed citations

Nagamine, Masanori, Taisuke Yamamoto, Jun Shigemura, et al.. (2018). The Psychological Impact of the Great East Japan Earthquake on Japan Ground Self-Defense Force Personnel: A Three-Wave, One-Year Longitudinal Study. Psychiatry. 81(3). 288–296. 13 indexed citations

Tsurutani, Junji, Katsumasa Kuroi, Tsutomu Iwasa, et al.. (2015). Phase I study of weekly nab‐paclitaxel combined with S‐1 in patients with human epidermal growth factor receptor type 2‐negative metastatic breast cancer. Cancer Science. 106(6). 734–739. 9 indexed citations

Miyazaki, Masaki, Masaki Miyazaki, Kouichi Uoto, et al.. (2015). Discovery of DS-5272 as a promising candidate: A potent and orally active p53–MDM2 interaction inhibitor. Bioorganic & Medicinal Chemistry. 23(10). 2360–2367. 31 indexed citations

Okamoto, Isamu, Masaki Miyazaki, Masayuki Takeda, et al.. (2014). Tolerability of Nintedanib (BIBF 1120) in Combination with Docetaxel: A Phase 1 Study in Japanese Patients with Previously Treated Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 10(2). 346–352. 30 indexed citations

Miyazaki, Masaki, Hidetoshi Nakamura, Shotaro Chubachi, et al.. (2014). Analysis of comorbid factors that increase the COPD assessment test scores. Respiratory Research. 15(1). 13–13. 82 indexed citations

Miyazaki, Masaki, Masaki Miyazaki, Hiroyuki Naito, et al.. (2013). Synthesis and evaluation of novel orally active p53–MDM2 interaction inhibitors. Bioorganic & Medicinal Chemistry. 21(14). 4319–4331. 26 indexed citations

Miyazaki, Masaki, et al.. (2012). Non-contact respiration measurement using structured light 3-D sensor. Society of Instrument and Control Engineers of Japan. 614–618. 41 indexed citations

Miyazaki, Masaki, Masaki Miyazaki, Haruko C. Kawato, et al.. (2012). Discovery of novel dihydroimidazothiazole derivatives as p53–MDM2 protein–protein interaction inhibitors: Synthesis, biological evaluation and structure–activity relationships. Bioorganic & Medicinal Chemistry Letters. 22(20). 6338–6342. 15 indexed citations

10.

Miyazaki, Masaki, Masaki Miyazaki, Hiroyuki Naito, et al.. (2012). Lead optimization of novel p53-MDM2 interaction inhibitors possessing dihydroimidazothiazole scaffold. Bioorganic & Medicinal Chemistry Letters. 23(3). 728–732. 25 indexed citations

11.

Hayashi, Hidetoshi, Junji Tsurutani, Norikazu Masuda, et al.. (2011). Phase II study of bi-weekly irinotecan for patients with previously treated HER2-negative metastatic breast cancer: KMBOG0610B. Breast Cancer. 20(2). 131–136. 14 indexed citations

12.

Takahashi, Shunji, Masaki Miyazaki, Isamu Okamoto, et al.. (2011). Phase I study of dasatinib (BMS‐354825) in Japanese patients with solid tumors. Cancer Science. 102(11). 2058–2064. 19 indexed citations

13.

Okamoto, Isamu, Koji Takeda, Haruko Daga, et al.. (2010). Dose-escalation study of pemetrexed in combination with carboplatin followed by pemetrexed maintenance therapy for advanced non-small cell lung cancer. Lung Cancer. 70(2). 168–173. 8 indexed citations

14.

Yanagawa, Youichi, Masaki Miyazaki, & Toshihisa Sakamoto. (2010). Relationship between abnormal pupillary reactivity and the outcome of a psychotropic drug overdose. The American Journal of Emergency Medicine. 28(6). 703–707. 3 indexed citations

15.

Kaneda, Hiroyasu, Isamu Okamoto, Hidetoshi Hayashi, et al.. (2010). Phase II Trial of Amrubicin for Second-Line Treatment of Advanced Non-small Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG0401). Journal of Thoracic Oncology. 5(1). 105–109. 15 indexed citations

16.

Okamoto, Isamu, Masaki Munakata, Masaki Miyazaki, et al.. (2009). Disturbance of the Growth Hormone-Insulin-like Growth Factor-1 Axis Associated with Poor Performance Status in Patients with Solid Tumors. Japanese Journal of Clinical Oncology. 40(3). 222–226. 3 indexed citations

17.

Miyazaki, Masaki, Aihide Yoshino, & Soichiro Nomura. (2009). Diagnosis of multiple anxiety disorders predicts the concurrent comorbidity of major depressive disorder. Comprehensive Psychiatry. 51(1). 15–18. 9 indexed citations

18.

Shimizu, Toshio, Isamu Okamoto, Kenji Tamura, et al.. (2009). Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent d-19575 (glufosfamide) in patients with solid tumors. Cancer Chemotherapy and Pharmacology. 65(2). 243–250. 20 indexed citations

19.

Nagamine, Masanori, Aihide Yoshino, Masaki Miyazaki, Yoshitomo Takahashi, & Soichiro Nomura. (2008). Effects of selective 5-HT1A agonist tandospirone on the rate and rhythmicity of binocular rivalry. Psychopharmacology. 198(2). 279–286. 20 indexed citations

20.

Miyazaki, Masaki, Shigesaburo Miyakoshi, Masahiro Kami, et al.. (2001). Systemic Fusariosis after a Preparative Regimen Including Thiotepa, VP-16 and Busulfan Used for Blood Stem Cell Transplantation in Hodgkin's Disease. Leukemia & lymphoma. 40(3-4). 441–444. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact